Your browser doesn't support javascript.
loading
Classification of COPD as ABCD according to GOLD 2011 and 2017 versions in COPD patients at University Medical Center in Ho Chi Minh City, Vietnam.
Nguyen-Nhu, Vinh; Nguyen, Lam-Phuoc; Duong-Quy, Sy; Le An, Pham; Bui-Minh, Tri.
Afiliação
  • Nguyen-Nhu V; Faculty of Medicine, University of Medicine and Pharmacy, Ho Chi Minh City; Department of Respiratory Functional Exploration, University Medical Center, Ho Chi Minh City. vinhnguyenmd@ump.edu.vn.
  • Nguyen LP; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City. lpnguyeny15@gmail.com.
  • Duong-Quy S; Bio-Medical Research Centre, Lam Dong Medical College, Da Lat. sduongquy.jfvp@gmail.com.
  • Le An P; Faculty of Medicine and Grant Innovation Center, University of Medicine and Pharmacy, Ho Chi Minh City. anpham_vn@yahoo.com.
  • Bui-Minh T; Grant Innovation Center, University of Medicine and Pharmacy, Ho Chi Minh City. buiminhtri17041992@gmail.com.
Article em En | MEDLINE | ID: mdl-37522870
ABSTRACT
In 2017, Global Initiative for Chronic Lung Disease (GOLD) made substantial changes to its ABCD group categorization. Although several studies had been conducted to assess the impact of the new GOLD category, there was no research on the change of the GOLD classification in Vietnam. This retrospective analysis was conducted at Asthma and COPD clinic at the University Medical Center in Ho Chi Minh City, Vietnam. Our study population comprised patients visiting Medical Center from January 2018 to January 2020. We categorized patients' demographic, clinical characteristics and pharmacotherapy based on GOLD 2011 and 2017 guidelines. A comparison between the two versions was also determined. A total of 457 patients were included in this study. The percentage of groups A, B, C and D according to GOLD 2011 was 5%, 20.8%, 13.1% and 61.1%; and according to GOLD 2017 was 6.1%, 34.1%, 12% and 47.8%, respectively. In terms of gender, male patients constituted nearly 95% of the study's population (433/457 patients). Regarding pharmacotherapy, approximately 20% of the low-risk group (group A-B) was overtreated with ICS components LABA+ICS (15.8%) and LAMA+LABA+ICS (3.8%). There were 13.3% and 1.1% of patients transferred from D to B and from C to A, respectively. All of them had lower FVC% pred, FEV1% pred and FEV1/FVC than the patients remained in group B or A (p<0.005). This is the first research in Vietnam to show the distribution of COPD patients using both the GOLD 2011 and GOLD 2017 criteria. There was 14% of patients reclassified from high-risk groups to low-risk groups when changing from 2011 to 2017 version and discordance of medications between guidelines and real-life practice. Therefore, clinicians should use their clinical competence to consider patients' conditions before deciding the appropriate therapeutic approach. Consequently, further studies were required to evaluate the effect of the change in GOLD classification.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Monaldi Arch Chest Dis Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Monaldi Arch Chest Dis Ano de publicação: 2023 Tipo de documento: Article